Advertisement
Australia markets closed
  • ALL ORDS

    7,837.40
    -100.10 (-1.26%)
     
  • ASX 200

    7,575.90
    -107.10 (-1.39%)
     
  • AUD/USD

    0.6534
    +0.0011 (+0.17%)
     
  • OIL

    83.67
    +0.10 (+0.12%)
     
  • GOLD

    2,349.00
    +6.50 (+0.28%)
     
  • Bitcoin AUD

    97,834.21
    -1,443.89 (-1.45%)
     
  • CMC Crypto 200

    1,330.91
    -65.63 (-4.70%)
     
  • AUD/EUR

    0.6106
    +0.0033 (+0.54%)
     
  • AUD/NZD

    1.0996
    +0.0039 (+0.35%)
     
  • NZX 50

    11,805.09
    -141.34 (-1.18%)
     
  • NASDAQ

    17,718.30
    +287.79 (+1.65%)
     
  • FTSE

    8,139.83
    +60.97 (+0.75%)
     
  • Dow Jones

    38,239.66
    +153.86 (+0.40%)
     
  • DAX

    18,161.01
    +243.73 (+1.36%)
     
  • Hang Seng

    17,651.15
    +366.61 (+2.12%)
     
  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     

Amazon says HBO Max is coming back to Prime streaming

By Liz Moyer

Investing.com -- Amazon.com (NASDAQ:AMZN) said HBO Max would return to its Prime Video streaming platform after a year hiatus.

HBO Max, owned by Warner Bros. Discovery (NASDAQ:WBD), will be available to Prime subscribers for $14.99 a month, including access to 15,000 hours of content from Warner Bros. Discovery networks.

The subscription through Amazon is the same price as its ad-free subscription on other platforms. HBO Max also offers a $9.99 ad-supported tier. Its website says HBO Max is available through not only Amazon Prime but through apps such as Roku (NASDAQ:ROKU) and the App Store as well as various cable operators.

ADVERTISEMENT

The streaming platform includes movies, television, and original HBO content. Statista says as of the third quarter, Warner Bros. Discovery had 95 million streaming customers across HBO, HBO Max, and Discovery+, while Amazon Prime has 200M worldwide subscribers.

Shares of Amazon fell 2.3%, while shares of Warner Bros. Discovery fell 4.7%.

Related Articles

Amazon says HBO Max is coming back to Prime streaming

U.S. lawmakers ease proposed curbs on Chinese chips amid corporate pushback

U.S. FDA grants priority review for Emergent's OTC opioid drug